Literature DB >> 23133462

Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum.

Natalie Grizenko1, David Dong Qi Zhang, Anna Polotskaia, Ridha Joober.   

Abstract

OBJECTIVE: This study evaluates whether attention-deficit/hyperactivity disorder (ADHD) children with a borderline intelligence quotient (IQ) (70≤FSIQ<80), normal IQ (80≤FSIQ<120) and high IQ (FSIQ≥120) respond differently to psychostimulant treatment.
METHOD: 502 children, aged 6 to 12 years, with an IQ range from 70 to 150 participated in a two-week, double-blind, placebo-controlled, crossover methylphenidate (MPH) trial.
RESULTS: In addition to differences in socioeconomic background and parental education, higher IQ children were found to present with less severe symptoms. No significant differences were found with regards to treatment response.
CONCLUSION: ADHD children within the normal and high levels of intellectual functioning all respond equally to psychostimulant treatment, and that proper medication management is necessary for all children with the disorder.

Entities:  

Keywords:  ADHD; IQ; methylphenidate response

Year:  2012        PMID: 23133462      PMCID: PMC3490529     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  15 in total

1.  Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

Authors:  M G Aman; R E Marks; S H Turbott; C P Wilsher; S N Merry
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-03       Impact factor: 8.829

2.  Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

3.  Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.

Authors:  J K Buitelaar; R J Van der Gaag; H Swaab-Barneveld; M Kuiper
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-08       Impact factor: 8.829

4.  Prediction of stimulant response in children with attention-deficit/hyperactivity disorder.

Authors:  J B Thomson; C K Varley
Journal:  J Child Adolesc Psychopharmacol       Date:  1998       Impact factor: 2.576

Review 5.  Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

Authors:  T Spencer; J Biederman; T Wilens; M Harding; D O'Donnell; S Griffin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 8.829

6.  The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

7.  Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour.

Authors:  E Taylor; R Schachar; G Thorley; H M Wieselberg; B Everitt; M Rutter
Journal:  Psychol Med       Date:  1987-02       Impact factor: 7.723

8.  Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?

Authors:  Natalie Grizenko; Michael Paci; Ridha Joober
Journal:  J Atten Disord       Date:  2009-09-18       Impact factor: 3.256

9.  Which treatment for whom for ADHD? Moderators of treatment response in the MTA.

Authors:  Elizabeth B Owens; Stephen P Hinshaw; Helen C Kraemer; L Eugene Arnold; Howard B Abikoff; Dennis P Cantwell; C Keith Conners; Glen Elliott; Laurence L Greenhill; Lily Hechtman; Betsy Hoza; Peter S Jensen; John S March; Jeffrey H Newcorn; William E Pelham; Joanne B Severe; James M Swanson; Benedetto Vitiello; Karen C Wells; Timothy Wigal
Journal:  J Consult Clin Psychol       Date:  2003-06

10.  Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status.

Authors:  S D Mayes; D L Crites; E O Bixler; F J Humphrey; R E Mattison
Journal:  Dev Med Child Neurol       Date:  1994-12       Impact factor: 5.449

View more
  2 in total

1.  A longitudinal twin study of the direction of effects between ADHD symptoms and IQ.

Authors:  Anna Sophie Rommel; Frühling Rijsdijk; Corina U Greven; Philip Asherson; Jonna Kuntsi
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 2.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.